AGL 40.02 Increased By ▲ 0.02 (0.05%)
AIRLINK 127.35 Increased By ▲ 0.31 (0.24%)
BOP 6.62 Decreased By ▼ -0.05 (-0.75%)
CNERGY 4.50 Decreased By ▼ -0.01 (-0.22%)
DCL 8.62 Increased By ▲ 0.07 (0.82%)
DFML 41.79 Increased By ▲ 0.35 (0.84%)
DGKC 87.70 Increased By ▲ 0.85 (0.98%)
FCCL 32.68 Increased By ▲ 0.40 (1.24%)
FFBL 65.10 Increased By ▲ 0.30 (0.46%)
FFL 10.28 Increased By ▲ 0.03 (0.29%)
HUBC 109.55 Decreased By ▼ -0.02 (-0.02%)
HUMNL 14.75 Increased By ▲ 0.07 (0.48%)
KEL 5.10 Increased By ▲ 0.05 (0.99%)
KOSM 7.58 Increased By ▲ 0.12 (1.61%)
MLCF 41.41 Increased By ▲ 0.03 (0.07%)
NBP 59.70 Decreased By ▼ -0.71 (-1.18%)
OGDC 193.85 Increased By ▲ 3.75 (1.97%)
PAEL 28.36 Increased By ▲ 0.53 (1.9%)
PIBTL 7.79 Decreased By ▼ -0.04 (-0.51%)
PPL 151.75 Increased By ▲ 1.69 (1.13%)
PRL 26.40 Decreased By ▼ -0.48 (-1.79%)
PTC 16.17 Increased By ▲ 0.10 (0.62%)
SEARL 84.00 Decreased By ▼ -2.00 (-2.33%)
TELE 7.69 Decreased By ▼ -0.02 (-0.26%)
TOMCL 35.40 Decreased By ▼ -0.01 (-0.03%)
TPLP 8.12 No Change ▼ 0.00 (0%)
TREET 16.08 Decreased By ▼ -0.33 (-2.01%)
TRG 52.60 Decreased By ▼ -0.69 (-1.29%)
UNITY 26.37 Increased By ▲ 0.21 (0.8%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
BR100 9,953 Increased By 69.4 (0.7%)
BR30 30,908 Increased By 307.7 (1.01%)
KSE100 93,812 Increased By 456.3 (0.49%)
KSE30 29,062 Increased By 130.9 (0.45%)
Markets Print 2019-10-31

Pharma stocks lift FTSE out of red

A rally in pharmaceutical stocks led by industry giants GlaxoSmithKline and AstraZeneca helped the FTSE 100 outshine most global peers on Wednesday while investors waited for the outcome of the US Federal Reserve's policy meeting.
Published October 31, 2019

A rally in pharmaceutical stocks led by industry giants GlaxoSmithKline and AstraZeneca helped the FTSE 100 outshine most global peers on Wednesday while investors waited for the outcome of the US Federal Reserve's policy meeting.

The FTSE 100 reversed early losses to close up 0.3%, with the pharma sub-index scaling an all-time high, up 2.5% after GSK again upgraded its 2019 targets.

The midcap index ended 0.3% lower as more domestically-focused companies braced for a wide array of Brexit possibilities after parliament approved a December election, leaving the next steps on Britain's departure from the European Union unclear.

Moves on both indexes were however subdued with investors waiting for the Fed to announce its policy decision.

The world's largest central bank is expected to lower interest rates for the third time this year as it looks to soothe an economy bruised by the protracted trade war with China.

UK Prime Minister Boris Johnson has won parliamentary support for an election on Dec. 12 as he seeks to break political deadlock after lawmakers forced his hand to delay to Brexit.

The FTSE 100 has gained just 15% since the UK voted to leave the EU in mid-2016, a far cry from the 50% rise for its Wall Street counterpart, the Dow, and reflecting the cautious view on UK equities while political uncertainty drags on.

The FTSE recorded a third month of losses for 2019 in October, with exporter stocks knocked by a firmer pound as no-deal Brexit fears abated.

GSK shares rose 2.5% to their highest in more than six years after the company hiked its annual profit forecast with sales of its shingles vaccine topping expectations.

Rival AstraZeneca was the biggest support to the main bourse with a near 3% gain after agreeing to sell the European rights for its schizophrenia drug to Cheplapharm.

Standard Chartered added 2.6% after a forecast-beating rise in quarterly profit, even though it flagged headwinds from a likely drop in global growth and lower interest rates.

Next dropped 3% after the retailer said sales in September were hit by unusually warm weather and small-cap passport maker De La Rue plunged 20% to its lowest in two decades after issuing another profit warning.

Among other midcaps, medical products maker ConvaTec

jumped 11% after quarterly revenue came in above market expectations and Computacenter advanced 9% following upbeat results for the last three months.

Copyright Reuters, 2019

Comments

Comments are closed.